Please login to the form below

Not currently logged in
Email:
Password:

Senior AstraZeneca exec jumps ship to small biotech

Briggs Morrison unexpectedly leaves the UK firm

AstraZeneca's chief medical officer Briggs Morrison is leaving the company, according to a statement from the Anglo-Swedish company.

He will leave the world's eight largest pharma firm to join a much smaller, privately owned biotech company, whose identity has not yet been publicly revealed.

AstraZeneca's chief executive, Pascal Soriot, will take over the job of late-stage drug development on an interim basis, according to news reports. 

Meanwhile Elisabeth Björk, an associate professor of medicine at Uppsala university and leads cardiovascular and metabolic drug development at AZ, now becomes acting chief medical officer.

Morrison's departure has surprised analysts as he joined AstraZeneca just three years ago and became a key member of the Soirot's new executive team. 

Colin White, an analyst at Datamonitor Healthcare, said: “It is surprising because he was brought in by Soriot and has been a key part of Soriot's leadership team.”

12 months ago the firm successfully rejected an $118bn takeover attempt from the US pharma giant Pfizer, saying it wanted to take an independent path. 

12th June 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics